Item 5. Other Information
Item
5. Other
Information.
During
the three months ended December 31, 2023, no director or officer of the Company adopted, modified or terminated a “Rule
10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a)
of Regulation S-K.
Item
6. Exhibits.
Exhibit
Number
Description
Method
of Filing
3.1
Composite
Articles of Incorporation, as amended through November 8, 2010 (incorporated by reference to Exhibit 3.1 to Annual Report
on Form 10-K for the fiscal year ended June 30, 2015)
Incorporated
by Reference
3.2
Amended
and Restated Bylaws, effective September 29, 2020 (incorporated by reference to Exhibit 3.1 to Current Report on Form
8-K filed September 29, 2020)
Incorporated
by Reference
10.1
Electromed,
Inc. 2023 Equity Incentive Plan (incorporated by reference to Exhibit 4.3 to Registration Statement on Form S-8 filed
November 30, 2023)*
Incorporated
by Reference
10.2
Rider
to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 13, 2023 (incorporated by references
to Exhibit 10.2 to Current Report on Form 8-K filed December 15, 2023)
Incorporated
by Reference
10.3
Form of Restricted Stock Agreement (Non-Employee Directors) under the 2023 Equity Incentive Plan*
Filed
Electronically
31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed
Electronically
31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed
Electronically
32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Furnished
Electronically
32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Furnished
Electronically
101
Financial
statements from the Quarterly Report on Form 10-Q for the period ended December 31, 2023, formatted in inline XBRL: (i) Condensed
Balance Sheets, (ii) Condensed Statements of Operations, (iii) Condensed Statements of Cash Flows, (iv) Condensed Statements
of Shareholders’ Equity, and (v) Notes to Condensed Financial Statements
Filed
Electronically
104
Cover
Page Interactive Data File (embedded within the inline XBRL Document)
Filed
Electronically
*
Management compensatory contract or arrangement
18
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
ELECTROMED, INC.
Date: February
13, 2024
/s/ James
L. Cunniff
James L. Cunniff, President
and Chief Executive Officer (duly authorized officer)
Date: February
13, 2024
/s/ Bradley
M. Nagel
Bradley M. Nagel, Chief Financial Officer (principal
financial officer and principal accounting officer)
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.